Bill Gates, the man who used to create viruses for computers so he could sell anti-viruses, decided with COVID that computers were child’s play. When the Covid “Plandemic” began, Gates and partners used their wealth and power to control the global Covid response — with little oversight.

To read this article in the following languages, click theTranslate Websitebutton below the author’s name.

Español, عربي, Hebrew, 中文, Dutch, Русский, Farsi, Portugues,Français, Deutsch, Italiano, 日本語,한국어, Türkçe, Српски. And 40 more languages.

The result was a gradual and significant shift in power from governments to a select group of non-governmental organizations. Supported by connections at the highest levels of Western governments and strengthened by long-standing relationships with pharmaceutical companies, these four organizations began to assume roles typically carried out by governments but without the same level of accountability.

The groups identified potential vaccine manufacturers and made strategic investments in the development of tests, treatments, and vaccines. They used their influence with the World Health Organization to help create an ambitious global distribution plan for delivering these COVID-19 tools to countries in need. However, the plan ultimately did not fulfill its original promises.

After the dust had settled in 2023, investigative journalistJordan Schachtel revealedthe extent of Gates’s profits from his investments in Pfizer partner BioNTech. When the Bill & Melinda Gates Foundation sold its BioNTech shares at the height of their value in 2021, it made 15 times its initial investment.

Schachtel analyzed Securities and Exchange Commission (SEC) filings and discovered that the Gates Foundation reduced its BioNTech holdings by 86 percent, from 1,038,674 shares to 148,674 shares, during the third quarter of 2021, which was BioNTech’s most successful quarter.

In September 2019, just months before the pandemic was declared, the foundation bought shares at a pre-public offering price of $18.10 each.When the foundation sold these shares at an average price of $300 each, it made a profit of approximately $260 million, which is more than 15 times its initial investment.

Schachtel reported that $242 million of the profit is untaxed because the foundation invested the money. Additionally, before the third quarter of 2021, the Gates Foundation sold 2 million shares and later sold 1.4 million shares of CureVac, a German-based mRNA company, earning another $50 million.

Gates had been a huge proponent of the vaccine, but after profiting from it in a huge way, most of which was excluded from taxes, he suddenly did a 180 and went in the other direction. At the time, Schachtel wrote this.

Source: Global Research